RxDoctor Payments Data

James Miller, DO

Family Medicine · Monroe, MINPI 1841297256

Payments from drug & device makers

$6,488in general payments, 2019–2025

Across 423 payments — averaging $15.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$924
  • Novo Nordisk$892
  • AbbVie$795
  • Exact Sciences$347
  • Pfizer$323
  • Jazz Pharmaceuticals Inc.$264
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$6,488100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,488 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$186,348
Medicare patients
341
Services billed
7,731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban238$142,631
JardianceEmpagliflozin95$117,173
TrulicityDulaglutide56$85,371
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$67,824
JanuviaSitagliptin Phosphate39$52,431
XareltoRivaroxaban25$38,107
RybelsusSemaglutide21$35,340
OzempicSemaglutide26$30,124
TrileptalOxcarbazepine12$27,323
TradjentaLinagliptin45$26,045
LinzessLinaclotide29$24,511
KeppraLevetiracetam11$22,040
MounjaroTirzepatide13$19,206
Breo ElliptaFluticasone/Vilanterol38$18,520
Lantus SolostarInsulin Glargine,hum.Rec.Anlog116$15,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Lyrica$323$152,867250 claims
Boehringer IngelheimJardiance, Tradjenta$127$143,218140 claims
Lilly USA, LLCTrulicity, Mounjaro, Lyumjev$924$108,43082 claims
GSKTrelegy Ellipta, Breo Ellipta$157$86,345100 claims
Novo NordiskRybelsus, Ozempic$892$65,46447 claims
Johnson & JohnsonXarelto, Invokana$190$51,04238 claims
AbbVieLinzess$795$24,51129 claims
AstraZenecaFarxiga$74$11,84311 claims
Astellas Pharma US IncMyrbetriq$70$5,56114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Monroe

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →